FDA clears Solventum's combined Restrata Matrix and V.A.C. Therapy
Tweet Send to a Friend
Solventum (NYSE: SOLV) announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the combined use of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




